Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Gishan Ratnayake"'
Autor:
Dharmenaan Palamuthusingam, Gishan Ratnayake, Carmel M Hawley, Elaine M Pascoe, David W Johnson, Magid Fahim
Publikováno v:
International Journal of Population Data Science, Vol 5, Iss 5 (2020)
Introduction The condition onset flag (COF) variable was introduced into hospitalization coding practice in 2008 to distinguish ICD coded diagnoses as either preexisting, new or status unknown. For datasets with multiple hospitalizations per particip
Externí odkaz:
https://doaj.org/article/962df5be23e04b4584bcfdd9b9d850f0
Autor:
Madeline Gough, Tashbib Khan, Kayden Kwah, Yaowu He, Gishan Ratnayake, Christopher Pyke, Cameron Snell, John Hooper, Thomas Kryza
Publikováno v:
Cancer Research. 83:P4-07
Introduction: CUB-domain containing- protein 1 (CDCP1) is a transmembrane receptor involved in the progression of several cancers. Recent studies demonstrate that CDCP1 is a rational target for the development of innovative targeted therapies for can
Set-up errors are a problem for pre-clinical irradiators that lack imaging capabilities. The aim of this study was to investigate the impact of the potential set-up errors on the dose distribution for a mouse with a xenographic tumour irradiated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4e3a9c03286318fb59d3124fb23a9c2
https://doi.org/10.21203/rs.3.rs-2730207/v1
https://doi.org/10.21203/rs.3.rs-2730207/v1
Autor:
Gishan Ratnayake, Simone Reinwald, Jack Edwards, Nicholas Wong, Di Yu, Rachel Ward, Robin Smith, Andrew Haydon, Pei M. Au, Menno C. van Zelm, Sashendra Senthi
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 173
The addition of stereotactic ablative radiotherapy (SABR) to immune checkpoint inhibitors (ICIs) has the potential to significantly improve outcomes in the treatment of metastatic melanoma. We analysed peripheral blood immune cells of patients receiv
Autor:
Mihir Shanker, Robert Mason, Zarnie Lwin, Kate Roberts, Gishan Ratnayake, Vikram K. Jain, Benjamin Chua, Brett G.M. Hughes, Kenneth J. O'Byrne, Margot Lehman
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 16:56-62
Background: Studies suggest that combining radiotherapy (RT) with programmed cell death protein 1 (PD-1) blockade may elicit a synergistic antitumor response. We aimed to assess whether prior or concurrent RT was associated with improved disease cont
Autor:
Gishan Ratnayake, Tracy Oh, Thomas G Hardy, Katrina Woodford, Jeremy D Ruben, Rhuju Mehta, Michael Dally, Rebecca Haward
Publikováno v:
Journal of Clinical Neuroscience. 68:162-167
We analysed the long-term outcomes of patients with primary optic nerve sheath meningioma (ONSM) treated with stereotactic radiotherapy (SRT). 26 patients with primary ONSM were treated with SRT between 2004 and 2013 at a single institution. SRT was
Autor:
Catherine Zajarski, Alan A McNab, Gishan Ratnayake, Sashendra Senthi, Jeremy D Ruben, Michael Dally
Publikováno v:
Ophthalmic Plastic & Reconstructive Surgery. 35:322-325
Purpose The objective of this study was to investigate the efficacy and safety of fractionated stereotactic radiotherapy in the treatment of cavernous venous malformation of the orbital apex. Methods The authors reviewed a prospective database from a
Autor:
Dharmenaan Palamuthusingam, Elaine M Pascoe, Carmel M Hawley, David W Johnson, Gishan Ratnayake, Stephen McDonald, Neil Boudville, Matthew Jose, Magid Fahim
Publikováno v:
Health Information Management Journal. :183335832210977
Background: Clinical quality registries provide rich and useful data for clinical quality monitoring and research purposes but are susceptible to data quality issues that can impact their usage. Objective: This study assessed the concordance between
Autor:
Elaine M. Pascoe, Gishan Ratnayake, Carmel M. Hawley, David W. Johnson, Dharmenaan Palamuthusingam, Magid Fahim
Publikováno v:
International Journal of Population Data Science, Vol 5, Iss 5 (2020)
IntroductionThe condition onset flag (COF) variable was introduced into hospitalization coding practice in 2008 to distinguish ICD coded diagnoses as either preexisting, new or status unknown. For datasets with multiple hospitalizations per participa
Autor:
Elaine M. Pascoe, Gishan Ratnayake, David W. Johnson, Matthew D. Jose, Carmel M. Hawley, Dharmenaan Palamuthusingam, Kym Kuenstner, Magid Fahim
Publikováno v:
International Journal for Quality in Health Care. 33
Background The condition onset flag (COF) variable was introduced into the hospitalization coding practice in 2008 to help distinguish between the new and pre-existing conditions. However, Australian datasets collected prior to 2008 lack the COF, pot